Evidence map›Paper›PMID 40680043›Full record

ArticlePloS one2025

Off-target sequence variations driven by the intrinsic properties of the Cas-sgRNA-DNA complex in genome editing.

Celine Kurniawan, Takeshi Itoh

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Celine KurniawanMaster Program in Global Agriculture Technology and Genomic Science, International College, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0009-0005-0114-3606
Takeshi ItohMaster Program in Global Agriculture Technology and Genomic Science, International College, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-6291-4233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-editing technologies hold significant potential across various biotechnological fields, yet concerns about possible risks, including off-target mutations, remain. To ensure safe and effective application, these unintended mutations must be rigorously examined and minimized. Computational approaches are anticipated to streamline the detection of off-target mutations; however, the performance of current prediction tools is limited, likely owing to insufficient knowledge of off-target mutation characteristics. In this study, we collected experimentally validated off-target mutation data and conducted a large-scale analysis of 177 nonredundant datasets obtained from six studies. We developed a method to assess the statistical significance of sequence pattern similarity and diversity between off-target sites. This method is based on a comparison of ordered relative entropy values for aligned target sequences, and it was compared with two other methods on the basis of Euclidean distance and the Pearson correlation coefficient. The three methods demonstrated clear correlations, indicating their validity. These methods were applied to 238 dataset pairs for the same target site, and it was revealed that off-target sequence patterns were quite similar across different experimental conditions, such as varying cell lines and independent experiments, suggesting that the intrinsic properties of the Cas-sgRNA-DNA complex play a key role in determining cleavage sites. However, newly engineered enzymes and those from different bacterial sources occasionally display unique off-target patterns, indicating the need for comprehensive evaluation of each new enzyme to develop reliable prediction tools. The insights gained from this study are expected to contribute to a better understanding of off-target mutation characteristics and support the development of more accurate computational prediction methods.

Indexed as

CRISPR-Cas SystemsDNAGene EditingRNA, Guide, CRISPR-Cas SystemsHumansMutationDNARNA, Guide, CRISPR-Cas Systems

Identifiers

PMID40680043
PMCPMC12273960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.